Expert Interviews

hello everyone this is the another example-content part for more imformation. Hello everyone this is the another example-content part for more imformation.Donec id elit non mi porta gravida at eget metus. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Etiam porta sem malesuada magna mollis euismod. Donec sed odio dui.

Donec id elit non mi porta gravida at eget metus. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Etiam porta sem malesuada magna mollis euismod. Donec sed odio dui.

Company Research

On 28th September, we visited Genetalks in hope of getting professional advice based on the current market and we were lucky enough to interview Dr. Zhuo Song. As the CTO, he provided us with very pertinent ideas about our project as well as comprehensive answers to our problems, which inspired us quite a lot.

Our interview questions fallen into three aspects as follows:
The first is about the limitations of existing methods of reducing gene expression such as gene knockout, RNAi and novel gene editing techniques. We hope that through having a clear view on what problems still exist, we can know which kind of improvements that we actually need to focus on.
Dr. Zhuo told us that all traditional methods of reducing gene expression had efficiency problems and moreover, they also yielded unknown effects.

The next one is safety issue. Although there are few clinical applications to degrade intracellular proteins at present, there is a general trend in market demand. The main problem is that the biological complexity leads to unknown practical application. Therefore, safety is the most essential topic we need to consider about.
Considering the safety issue about our project, Dr. Zhou raised two aspects.
1.Unknown effects in vivo environment
Dr. Zhou mentioned that the purpose of protein-specific degradation technology is to degrade abnormal or overexpressed proteins. The implementation of this method in vivo must ensure that it does not introduce other problems that are adverse to the organism. It should be noted that in vitro and in vivo environment are not equivalent.
2.Excessive protein degradation
From an evolutionary point of view, it is only the amount of protein present in an organism that determines its actual function. Therefore, the degree of protein degradation on the biological effects should also be taken into account. For example, the removal of certain overexpressed proteins may affect the normal physiological activities of the organism.

Last but not least, it is about the possibility of application. We hope based on his abundant market experience, Dr. Zhou can give us more detailed suggestions about the approaches to clinical application and marketization of our project. Here are some significant answers we get.
1. What difficulties do you think our project will meet in the result transformation?
Dr. Zhou: The first thing must be considered is security issues. Also, you have to look for clinical trials of medical institutions that are willing to cooperate. What’s more, you need to pay attention to the negative or positive result of the standard.
2. During the transformation of achievements in China, the situation that the intermediate process of commercialization and industrialization of scientific and technological achievements is missing, always occurs, which is related to both universities and enterprises. Can you give some suggestions to avoid the "blank" area?
Dr. Zhou: Much of the reason for the "pilot" area actually lies in the role of government. While protecting the intellectual property rights is to protect the benefits of universities, the cost of subsequent transformation is very high, which is related to the cost of patent and development. Foreign commercial interests are only granted to a company, and the risk of success or failure is shared. In our country, patents have not really transformed.
3. If the improved protein degradation method in our study is introduced, can it play a significant role in diseases such as malignant tumors in the future?
Dr. Zhou: If the improved protein degradation method in the subject is applied, the following problems should be considered:
a) Can protein degradation last functioning?
b) Are there any incidental effects of unknown after degradation?
c) To what extent can the degradation be? How do you control that?
d) Can the degradation cause cell idle?
e) Concerns about sensitivity and specificity
Try to think about the dynamics of the control network and choose a clear application point.
If these problems can be solved, this method will play an important role in the application of diseases such as tumors.

Speeches at Streets & Survey

To make our work responsible and good for the world, people’s attitude is an important factor. We did a survey of people’s cognition of traditional curing methods of tumor, cancer and Alzheimer’s disease and potential methods using PR PREDATOR. In addition to investigating this issue, we worked hard to engage with people by delivering speeches at streets. We inspired people by introducing our project in its future application and raised their awareness of preventing the fatal diseases mentioned above. The results of survey and details about speeches can be seen at Education Page.(超链接好像是at Education Page)

Through the survey and engagement with the public, we had a clear view of people’s attitude towards “target therapy” and the future application of PR PREDATOR. Since many of people involved had a positive attitude to our project, we would continue working on experiment and try to exert a greater influence in maintaining health.

Co-Research on Fundamental Study

Knowing that there was a gap between scientific research and product development in China, with the proposal of team Tianjin team, six universities worked together to make research on how the laboratory results are converted to market products. We conducted market research on the products based on fundamental study and then investigated the evaluation mechanism. The final report of commercialization of research findings worked as a reference guide for foundational advance.

The body of the report is the analysis and research of this transformation process (with theory and case study) and our projects. The theoretical part was completed by iGEM Tianjin and our team. The case study was completed by OUC-China and Jilin_China. In our own project analysis section, ZJU-Chian and XJTU-China wrote a detailed application plan.

The theoretical analysis we were in charge of is as follows:

The transformation of fundamental research results of Chinese universities basically follows the IUR mode, that is, the synergy and integration of Industry, University and Research in terms of function and resource advantages. This is the docking and coupling of technological innovation in the upper, middle and lower reaches. With the support of government policies and regulations, in the communication with potential customers, it has gradually shifted to the coordinated development mode of GCIUR (Government-Customer-Industry-University-Research).

Early exploration and planning of scientific and technological achievements

Scientific research
Universities and research institutions are guided by scientific achievements. The core appeal is the transformation of them, which is combined with the demands of enterprises to form a supply and demand market for collaborative innovation. The transformation pathway is from the extensive basic research to technological invention.

Value assessment
The value of scientific and technological achievements includes science, technology, market, economic profits, and social influence factors. In the evaluation system, scientific factors mainly refer to science, academic value and development degree. Technical factors include advancement, maturity, patents, market docking and risks. The influence of market comes from the environment, demands, period and competition risks. The expected income, development cycle and cost are mainly included in the factor of economic benefits. And social influence refers to resource conservation, employment increase, environmental impact, etc.

At present, there are many evaluation index systems for the transformation efficiency.
First-level Indicators:
1.Input
Manpower:
The proportion of scientific and technological personnel
The proportion of government funds
Fund:
From government
From enterprises and institutions
2.Output
Market transformation income (technological transfer income)

CFDA Inquiry

hello everyone this is the another example-content part for more imformation. Hello everyone this is the another example-content part for more imformation.Donec id elit non mi porta gravida at eget metus. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Etiam porta sem malesuada magna mollis euismod. Donec sed odio dui.

Donec id elit non mi porta gravida at eget metus. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Etiam porta sem malesuada magna mollis euismod. Donec sed odio dui.

Our Work

Our Work

hello everyone this is the another example-content part for more imformation. Hello everyone this is the another example-content part for more imformation.Donec id elit non mi porta gravida at eget metus. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Etiam porta sem malesuada magna mollis euismod. Donec sed odio dui.

Donec id elit non mi porta gravida at eget metus. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Etiam porta sem malesuada magna mollis euismod. Donec sed odio dui.